Concord Investment Counsel »

iShares Dow Jones US Pharm Indx shares owned by Concord Investment Counsel

Quarter-by-quarter ownership of iShares Dow Jones US Pharm Indx (IHE) shares owned by Concord Investment Counsel from 13F filings

Historical chart of Concord Investment Counsel investment in iShares Dow Jones US Pharm Indx

Tip: Access up to 7 years of quarterly data

All positions including iShares Dow Jones US Pharm Indx held by Concord Investment Counsel consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in iShares Dow Jones US Pharm Indx by Concord Investment Counsel

Quarter filed Position value Share count Share price at filing
2024-03-31 $3.9M 57k 67.89

More positions owned by Concord Investment Counsel

NVIDIA Corporation (NVDA)
Apple (AAPL)
Select Sector Spdr Tr Indl (XLI)
Amazon (AMZN)
Microsoft Corporation (MSFT)
UnitedHealth (UNH)
Alphabet Cap Stk Cl A (GOOGL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Meta Platforms Cl A (META)
Select Sector Spdr Tr Sbi Cons Stpls (XLP)
Select Sector Spdr Tr Energy (XLE)
Netflix (NFLX)
JPMorgan Chase & Co. (JPM)
Select Sector Spdr Tr Technology (XLK)
Bank of America Corporation (BAC)

View all positions for Concord Investment Counsel

Top funds holding iShares Dow Jones US Pharm Indx

Fisher Investments
Morgan Stanley
Bank of America Corporation
Accurate Wealth Management
Royal Bank of Canada
Brown Advisory Holdings Incorporated
Virtue Capital Management
LPL Financial
Wells Fargo & Company
Concord Investment Counsel
Raymond James & Associates
Susquehanna International
Peapack Gladstone Financial Corp
Citadel Advisors
Southern Capital Advisors

View all funds holding iShares Dow Jones US Pharm Indx